prochlorperazine has been researched along with Dizzyness in 8 studies
Prochlorperazine: A phenothiazine antipsychotic used principally in the treatment of NAUSEA; VOMITING; and VERTIGO. It is more likely than CHLORPROMAZINE to cause EXTRAPYRAMIDAL DISORDERS. (From Martindale, The Extra Pharmacopoeia, 30th ed, p612)
prochlorperazine : A member of the class of phenothiazines that is 10H-phenothiazine having a chloro substituent at the 2-position and a 3-(4-methylpiperazin-1-yl)propyl group at the N-10 position.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Considering the prevailing concerns about extrapyramidal symptoms (EPS) associated with oral prochlorperazine, this study was conducted to assess the safety of oral prochlorperazine (in recommended dose/duration) in the management of acute dizziness." | 7.96 | The Real-World Safety and Effectiveness of Prochlorperazine in Indian Patients with Dizziness. ( A, B; Haldipur, D; Krishnamurthy, N, 2020) |
| " While prochlorperazine is effective in relieving nausea and vomiting, its low bioavailability following first pass metabolism in the liver and metabolism in the intestinal wall, compounded by the likelihood of regurgitation in the nauseous patient, may limit the therapeutic value of the oral preparation." | 6.69 | Comparison of buccal and oral prochlorperazine in the treatment of dizziness associated with nausea and/or vomiting. ( Bond, CM, 1998) |
| "Considering the prevailing concerns about extrapyramidal symptoms (EPS) associated with oral prochlorperazine, this study was conducted to assess the safety of oral prochlorperazine (in recommended dose/duration) in the management of acute dizziness." | 3.96 | The Real-World Safety and Effectiveness of Prochlorperazine in Indian Patients with Dizziness. ( A, B; Haldipur, D; Krishnamurthy, N, 2020) |
| "Prescribers should consider the possible contributing role of newly initiated medicines with the potential to cause of dizziness, and where possible address this through dose reduction or cessation of the medicine, rather than prescribing prochlorperazine." | 3.76 | Increased risk of hip fracture in the elderly associated with prochlorperazine: is a prescribing cascade contributing? ( Caughey, GE; Gilbert, AL; Pratt, N; Roughead, EE; Shakib, S; Vitry, AI, 2010) |
| " While prochlorperazine is effective in relieving nausea and vomiting, its low bioavailability following first pass metabolism in the liver and metabolism in the intestinal wall, compounded by the likelihood of regurgitation in the nauseous patient, may limit the therapeutic value of the oral preparation." | 2.69 | Comparison of buccal and oral prochlorperazine in the treatment of dizziness associated with nausea and/or vomiting. ( Bond, CM, 1998) |
| "Nabilone is an effective oral anti-emetic drug for moderately toxic chemotherapy, but the range and unpredictability of its side-effects warrant caution in its use." | 2.65 | Anti-emetic efficacy and toxicity of nabilone, a synthetic cannabinoid, in lung cancer chemotherapy. ( Ahmedzai, S; Calder, IT; Carlyle, DL; Moran, F, 1983) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (25.00) | 18.7374 |
| 1990's | 3 (37.50) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (25.00) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Haldipur, D | 1 |
| Krishnamurthy, N | 1 |
| A, B | 1 |
| Smith, LA | 1 |
| Azariah, F | 1 |
| Lavender, VT | 1 |
| Stoner, NS | 1 |
| Bettiol, S | 1 |
| Caughey, GE | 1 |
| Roughead, EE | 1 |
| Pratt, N | 1 |
| Shakib, S | 1 |
| Vitry, AI | 1 |
| Gilbert, AL | 1 |
| Ahmedzai, S | 1 |
| Carlyle, DL | 1 |
| Calder, IT | 1 |
| Moran, F | 1 |
| Baloh, RW | 1 |
| Bond, CM | 1 |
| Besson, JA | 1 |
| Palin, AN | 1 |
| Ward, AE | 1 |
2 reviews available for prochlorperazine and Dizzyness
| Article | Year |
|---|---|
Cannabinoids for nausea and vomiting in adults with cancer receiving chemotherapy.
Topics: Adult; Antiemetics; Antineoplastic Agents; Cannabinoids; Chlorpromazine; Dizziness; Domperidone; Eup | 2015 |
Approach to the dizzy patient.
Topics: Anxiety Disorders; Brain Diseases; Diazepam; Dizziness; Heart Diseases; Humans; Meclizine; Meniere D | 1994 |
3 trials available for prochlorperazine and Dizzyness
| Article | Year |
|---|---|
Anti-emetic efficacy and toxicity of nabilone, a synthetic cannabinoid, in lung cancer chemotherapy.
Topics: Adult; Aged; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cli | 1983 |
Comparison of buccal and oral prochlorperazine in the treatment of dizziness associated with nausea and/or vomiting.
Topics: Administration, Oral; Adolescent; Adult; Aged; Antiemetics; Cheek; Dizziness; Double-Blind Method; F | 1998 |
Studies of prochlorperazine as a buccal tablet (Buccastem) and an oral tablet (Stemetil) for the treatment of dizziness, nausea or vomiting in a general practice setting.
Topics: Administration, Buccal; Administration, Oral; Adult; Aged; Clinical Trials as Topic; Dizziness; Doub | 1988 |
3 other studies available for prochlorperazine and Dizzyness
| Article | Year |
|---|---|
The Real-World Safety and Effectiveness of Prochlorperazine in Indian Patients with Dizziness.
Topics: Antiemetics; Dizziness; Female; Humans; India; Male; Prochlorperazine; Prospective Studies; Vomiting | 2020 |
Increased risk of hip fracture in the elderly associated with prochlorperazine: is a prescribing cascade contributing?
Topics: Aged; Aged, 80 and over; Antiemetics; Australia; Databases, Factual; Dizziness; Drug-Related Side Ef | 2010 |
Tardive dyskinesia, depression and ECT.
Topics: Aged; Aged, 80 and over; Depressive Disorder; Dizziness; Dyskinesia, Drug-Induced; Electroconvulsive | 1991 |